Skip to main content

Table 1 (abstract P84). Characteristics of uSAID patients with heterozygous MEFV mutations

From: Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)

 

E148Q group (n=8)

Non-E148Q group (n=17)

p value

Complete response, (%)

2 (25)

12 (70.6)

0.03

Mean episode duration (days), (SD)

8.3 (6.5)

3.7 (1.4)

0.009

Asian ancestry, (%)

3 (37.5)

0 (0)

0.04

GI symptom, (%)

5 (62.5)

8 (47.1)

0.47

MSK symptom, (%)

3 (37.5)

9 (52.9)

0.47

Pharyngitis, (%)

3 (37.5)

5 (29.4)

0.69

Rash, (%)

3 (37.5)

11 (64.7)

0.20